A Phase II, Multi-Center, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Lenalidomide (Revlimid) in Combination With Dexamethasone in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Dexamethasone; Lenalidomide
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Sponsors Celgene Corporation
- 09 Sep 2009 Actual patient number (26) added as reported by ClinicalTrials.gov.
- 12 May 2009 Planned end date changed from Jun 2008 to Dec 2008 as reported by ClinicalTrials.gov.
- 09 Nov 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.